Last reviewed · How we verify

Sodium ferric gluconate — Competitive Intelligence Brief

Sodium ferric gluconate (Sodium ferric gluconate) competitive landscape: 6 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Iron replacement agent. Area: Hematology.

marketed Iron replacement agent Iron (Fe3+) delivery system Hematology Small molecule Live · refreshed every 30 min

Target snapshot

Sodium ferric gluconate (Sodium ferric gluconate) — University of North Carolina, Chapel Hill. Sodium ferric gluconate is an iron replacement therapy that delivers ferric iron in a stable gluconate complex to replenish depleted iron stores.

Comparator set (6 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

DrugGenericSponsorPhaseClassTargetApproval / PDUFA
Sodium ferric gluconate TARGET Sodium ferric gluconate University of North Carolina, Chapel Hill marketed Iron replacement agent Iron (Fe3+) delivery system
Aggressive iron dextran supplementation Aggressive iron dextran supplementation Shanghai East Hospital marketed Iron replacement agent Iron (Fe3+) for hemoglobin and myoglobin synthesis
Intravenous iron sucrose Intravenous iron sucrose Ain Shams University marketed Iron replacement agent
intravenous iron carboxymaltose intravenous iron carboxymaltose University of Zurich marketed Intravenous iron replacement agent Iron (Fe³⁺) delivery system; transferrin receptor-mediated uptake
Venofer® Venofer® Azad Pharma AG marketed Iron replacement agent
Vifor and EPO Vifor and EPO Kunshan First People's Hospital Affiliated to Jiangsu University marketed Iron replacement agent and erythropoiesis-stimulating agent (ESA) Iron (ferric ion) and erythropoietin receptor (EPOR)
SFP SFP Rockwell Medical Technologies, Inc. marketed Intravenous iron replacement agent Iron (Fe3+) for hemoglobin synthesis and erythropoiesis

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Iron replacement agent class)

  1. University of Maryland, Baltimore · 2 drugs in this class
  2. Ain Shams University · 1 drug in this class
  3. American Regent, Inc. · 1 drug in this class
  4. Azad Pharma AG · 1 drug in this class
  5. CN NGANOU-GNINDJIO, MD, MSc · 1 drug in this class
  6. China-Japan Friendship Hospital · 1 drug in this class
  7. Hallym University Medical Center · 1 drug in this class
  8. J. Uriach and Company · 1 drug in this class
  9. JW Pharmaceutical · 1 drug in this class
  10. Prince of Wales Hospital, Shatin, Hong Kong · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Sodium ferric gluconate — Competitive Intelligence Brief. https://druglandscape.com/ci/sodium-ferric-gluconate. Accessed 2026-05-16.

Build your own brief

Pick any drug + add comparators: